Robinson James George
- SEC CIK
- 0001651844
No open-market purchases or sales filed in the past year.
Current role at each company
- NYMXF Nymox Pharmaceutical CorpDirector, 10% Owneras of Jun 26, 2023
- ALID Allied Corp.Director, 10% Owneras of Apr 27, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Robinson James George as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NYMXF Nymox Pharmaceutical Corp
Director, 10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 (view filing)10:27 AM ET | Apr 25-27 | 62 days | Robinson James GeorgeDirector, 10% Owner | PPurchase | +80.0K | $0.46 | +$36.8K | +1.7%4.78M after | Amended2 lots |
| May 6, 2022 (view filing) | May 2 | 4 daysLate | Robinson James GeorgeDirector | PPurchase | +1.15M | $1.65 | +$1.90M | +32.4%4.70M after | |
| May 6, 2022 (view filing) | May 2 | 4 daysLate | Robinson James GeorgeDirector | PPurchase | +1.15M | $0.00 | $0 | –1.15M after | Derivative |
ALID Allied Corp.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2023 (view filing)4:50 PM ET | Apr 25-27 | 2 days | Robinson James GeorgeDirector, 10% Owner | PPurchase | +80.0K | $0.46 | +$36.8K | +1.7%4.78M after | 2 lots |